Inside informationFrench
Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Abivax
- Filed
- 30/07/2026, 22:05
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- French
- AMF reference
- 008606_20260730